WHO’s Strategic Advisory Group of Experts on Immunization (SAGE) has issued its policy recommendations for the rollout of the first COVID-19 vaccine approved for emergency use, the Pfizer-BioNTech COVID-19 vaccine.According to SAGE, the Pfizer-BioNTech COVID-19 mRNA vaccine is safe and effective.
Nevertheless, there are specific populations for whom vaccination is not recommended, either due to contraindications, lack of supply, or limited data.
These populations currently include people with a history of severe allergies, most pregnant women, international travellers who are not part of a prioritized group, and children under 16.The priority is to start vaccinating health workers at high risk of exposure, followed by older adults, before